Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 73 | 2023 | 696 | 14.730 |
Why?
|
| Arthroplasty, Replacement, Hip | 48 | 2023 | 857 | 10.050 |
Why?
|
| Knee Prosthesis | 28 | 2023 | 244 | 8.660 |
Why?
|
| Knee Joint | 42 | 2022 | 800 | 6.330 |
Why?
|
| Hip Prosthesis | 26 | 2023 | 569 | 6.240 |
Why?
|
| Femur | 20 | 2020 | 393 | 4.740 |
Why?
|
| Surgery, Computer-Assisted | 16 | 2017 | 60 | 4.610 |
Why?
|
| Prosthesis Failure | 24 | 2023 | 530 | 3.620 |
Why?
|
| Prosthesis Design | 28 | 2023 | 494 | 3.320 |
Why?
|
| Osteoarthritis, Knee | 20 | 2019 | 382 | 3.270 |
Why?
|
| Hip Joint | 17 | 2017 | 357 | 3.160 |
Why?
|
| Tibia | 17 | 2019 | 266 | 3.130 |
Why?
|
| Middle Aged | 80 | 2021 | 9952 | 2.840 |
Why?
|
| Retrospective Studies | 55 | 2022 | 3325 | 2.740 |
Why?
|
| Bone Cements | 7 | 2023 | 90 | 2.630 |
Why?
|
| Reoperation | 25 | 2023 | 927 | 2.620 |
Why?
|
| Aged | 70 | 2021 | 9618 | 2.490 |
Why?
|
| Humans | 123 | 2023 | 29801 | 2.440 |
Why?
|
| Postoperative Period | 22 | 2020 | 286 | 2.300 |
Why?
|
| Female | 82 | 2022 | 16402 | 2.200 |
Why?
|
| Male | 81 | 2022 | 15844 | 2.200 |
Why?
|
| Pain, Postoperative | 11 | 2020 | 318 | 2.040 |
Why?
|
| Postoperative Complications | 15 | 2022 | 957 | 1.930 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 96 | 1.800 |
Why?
|
| Patient Satisfaction | 8 | 2019 | 297 | 1.780 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 778 | 1.730 |
Why?
|
| Metal-on-Metal Joint Prostheses | 5 | 2017 | 53 | 1.720 |
Why?
|
| Prospective Studies | 21 | 2020 | 1821 | 1.630 |
Why?
|
| Acetabulum | 6 | 2016 | 198 | 1.620 |
Why?
|
| Treatment Outcome | 31 | 2023 | 3557 | 1.590 |
Why?
|
| Bone Malalignment | 7 | 2014 | 20 | 1.570 |
Why?
|
| Adult | 38 | 2019 | 8730 | 1.500 |
Why?
|
| Anticoagulants | 4 | 2015 | 102 | 1.490 |
Why?
|
| Venous Thromboembolism | 3 | 2015 | 37 | 1.460 |
Why?
|
| Joint Diseases | 4 | 2016 | 111 | 1.400 |
Why?
|
| Range of Motion, Articular | 15 | 2017 | 707 | 1.350 |
Why?
|
| Radiography | 20 | 2017 | 678 | 1.340 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2017 | 1246 | 1.270 |
Why?
|
| Recovery of Function | 11 | 2016 | 291 | 1.250 |
Why?
|
| Noise | 3 | 2017 | 24 | 1.240 |
Why?
|
| Warfarin | 4 | 2015 | 38 | 1.220 |
Why?
|
| Bone Density | 3 | 2018 | 151 | 1.170 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2016 | 222 | 1.150 |
Why?
|
| Chromium | 3 | 2016 | 92 | 1.130 |
Why?
|
| Cobalt | 3 | 2016 | 110 | 1.110 |
Why?
|
| Metals | 4 | 2017 | 149 | 1.100 |
Why?
|
| Prosthesis-Related Infections | 5 | 2020 | 215 | 1.070 |
Why?
|
| Aspirin | 3 | 2015 | 84 | 1.050 |
Why?
|
| Foreign-Body Reaction | 2 | 2017 | 28 | 1.050 |
Why?
|
| Venous Thrombosis | 2 | 2015 | 42 | 0.960 |
Why?
|
| Osteolysis | 2 | 2017 | 138 | 0.940 |
Why?
|
| Titanium | 4 | 2020 | 197 | 0.890 |
Why?
|
| Arthritis | 4 | 2020 | 106 | 0.860 |
Why?
|
| Biomechanical Phenomena | 11 | 2017 | 680 | 0.850 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.840 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 4930 | 0.840 |
Why?
|
| Hip Dislocation | 6 | 2023 | 64 | 0.830 |
Why?
|
| Synovial Fluid | 2 | 2020 | 124 | 0.820 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2021 | 4 | 0.810 |
Why?
|
| Arthroplasty, Replacement | 4 | 2013 | 149 | 0.790 |
Why?
|
| Age Factors | 9 | 2018 | 852 | 0.780 |
Why?
|
| Accelerometry | 2 | 2012 | 87 | 0.770 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 1186 | 0.770 |
Why?
|
| Surgical Wound | 2 | 2018 | 11 | 0.770 |
Why?
|
| Surgical Wound Infection | 3 | 2021 | 98 | 0.730 |
Why?
|
| Registries | 2 | 2018 | 191 | 0.720 |
Why?
|
| Pain Measurement | 4 | 2016 | 468 | 0.710 |
Why?
|
| Specimen Handling | 1 | 2020 | 50 | 0.700 |
Why?
|
| Lower Extremity | 3 | 2015 | 38 | 0.700 |
Why?
|
| Periprosthetic Fractures | 1 | 2020 | 32 | 0.680 |
Why?
|
| Joint Dislocations | 3 | 2023 | 58 | 0.650 |
Why?
|
| Computer-Aided Design | 2 | 2016 | 16 | 0.650 |
Why?
|
| Incidence | 9 | 2018 | 759 | 0.650 |
Why?
|
| Equipment Failure Analysis | 4 | 2014 | 106 | 0.650 |
Why?
|
| Intermittent Pneumatic Compression Devices | 2 | 2015 | 7 | 0.620 |
Why?
|
| Acceleration | 3 | 2012 | 20 | 0.610 |
Why?
|
| Research Design | 3 | 2015 | 214 | 0.600 |
Why?
|
| Ankle Joint | 5 | 2016 | 41 | 0.590 |
Why?
|
| Genu Varum | 1 | 2017 | 3 | 0.580 |
Why?
|
| Cadaver | 4 | 2012 | 362 | 0.580 |
Why?
|
| Weight-Bearing | 2 | 2014 | 168 | 0.580 |
Why?
|
| Risk Factors | 9 | 2022 | 2465 | 0.570 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2019 | 384 | 0.570 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 1126 | 0.560 |
Why?
|
| Risk Assessment | 3 | 2018 | 683 | 0.560 |
Why?
|
| Pelvic Bones | 1 | 2016 | 20 | 0.550 |
Why?
|
| Femur Neck | 1 | 2016 | 19 | 0.540 |
Why?
|
| Supine Position | 1 | 2016 | 15 | 0.540 |
Why?
|
| Prosthesis Fitting | 2 | 2013 | 22 | 0.540 |
Why?
|
| Young Adult | 10 | 2019 | 1966 | 0.530 |
Why?
|
| Analgesics, Opioid | 6 | 2020 | 221 | 0.530 |
Why?
|
| Posture | 4 | 2017 | 79 | 0.520 |
Why?
|
| Patient Discharge | 3 | 2019 | 151 | 0.520 |
Why?
|
| Hypersensitivity | 1 | 2016 | 46 | 0.510 |
Why?
|
| Orthopedic Procedures | 1 | 2018 | 322 | 0.480 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 23 | 0.480 |
Why?
|
| Osteoarthritis | 2 | 2016 | 366 | 0.450 |
Why?
|
| Patella | 1 | 2014 | 83 | 0.450 |
Why?
|
| Reproducibility of Results | 6 | 2019 | 801 | 0.440 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 90 | 0.440 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 12 | 0.440 |
Why?
|
| Fibrosis | 1 | 2013 | 38 | 0.430 |
Why?
|
| Patellofemoral Joint | 1 | 2014 | 52 | 0.430 |
Why?
|
| Missouri | 4 | 2016 | 27 | 0.420 |
Why?
|
| Computer Simulation | 2 | 2016 | 218 | 0.420 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 28 | 0.410 |
Why?
|
| Time Factors | 8 | 2019 | 1640 | 0.410 |
Why?
|
| Muscular Diseases | 1 | 2012 | 18 | 0.400 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 401 | 0.390 |
Why?
|
| Blood Transfusion | 4 | 2022 | 65 | 0.380 |
Why?
|
| United States | 9 | 2018 | 2344 | 0.380 |
Why?
|
| Viscosity | 4 | 2019 | 10 | 0.370 |
Why?
|
| Rotation | 4 | 2014 | 142 | 0.370 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 490 | 0.370 |
Why?
|
| Porosity | 2 | 2022 | 69 | 0.370 |
Why?
|
| Pain | 4 | 2019 | 396 | 0.370 |
Why?
|
| Osteoporosis | 1 | 2011 | 84 | 0.360 |
Why?
|
| Adolescent | 6 | 2019 | 2331 | 0.350 |
Why?
|
| Joint Prosthesis | 4 | 2019 | 80 | 0.340 |
Why?
|
| Patient Positioning | 4 | 2017 | 37 | 0.340 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1859 | 0.340 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 534 | 0.330 |
Why?
|
| Spinal Fusion | 1 | 2016 | 518 | 0.330 |
Why?
|
| Rotator Cuff | 1 | 2012 | 266 | 0.330 |
Why?
|
| Length of Stay | 5 | 2019 | 320 | 0.320 |
Why?
|
| Body Mass Index | 4 | 2020 | 425 | 0.320 |
Why?
|
| Arthroscopy | 2 | 2014 | 817 | 0.310 |
Why?
|
| Femur Head | 4 | 2023 | 65 | 0.310 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2018 | 16 | 0.300 |
Why?
|
| Joint Instability | 4 | 2019 | 389 | 0.300 |
Why?
|
| Chi-Square Distribution | 3 | 2016 | 147 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2019 | 363 | 0.290 |
Why?
|
| Arthroplasty, Replacement, Elbow | 2 | 2019 | 6 | 0.280 |
Why?
|
| Corrosion | 3 | 2017 | 129 | 0.280 |
Why?
|
| Absorptiometry, Photon | 2 | 2018 | 84 | 0.280 |
Why?
|
| Osteocytes | 2 | 2019 | 15 | 0.280 |
Why?
|
| Polyethylene | 4 | 2019 | 119 | 0.280 |
Why?
|
| Blood Loss, Surgical | 2 | 2020 | 66 | 0.280 |
Why?
|
| Hip Fractures | 2 | 2018 | 33 | 0.270 |
Why?
|
| Pain Management | 4 | 2020 | 144 | 0.270 |
Why?
|
| Patient Readmission | 3 | 2018 | 124 | 0.260 |
Why?
|
| Sex Factors | 3 | 2017 | 497 | 0.260 |
Why?
|
| Elbow Joint | 2 | 2019 | 131 | 0.250 |
Why?
|
| Hemorrhage | 2 | 2015 | 75 | 0.250 |
Why?
|
| Hand | 2 | 2018 | 45 | 0.250 |
Why?
|
| Awards and Prizes | 2 | 2016 | 25 | 0.240 |
Why?
|
| Cytokines | 2 | 2019 | 350 | 0.240 |
Why?
|
| Stress, Mechanical | 3 | 2014 | 169 | 0.230 |
Why?
|
| Comorbidity | 2 | 2022 | 504 | 0.220 |
Why?
|
| Cohort Studies | 4 | 2020 | 1952 | 0.220 |
Why?
|
| Therapeutic Irrigation | 2 | 2020 | 66 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2022 | 520 | 0.220 |
Why?
|
| Gait | 2 | 2017 | 406 | 0.210 |
Why?
|
| Urinary Retention | 1 | 2022 | 11 | 0.210 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 16 | 0.210 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 32 | 0.210 |
Why?
|
| Patient Selection | 2 | 2014 | 234 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2022 | 53 | 0.210 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 49 | 0.210 |
Why?
|
| Vitamin D | 1 | 2022 | 32 | 0.210 |
Why?
|
| Algorithms | 3 | 2019 | 400 | 0.200 |
Why?
|
| Cementation | 1 | 2021 | 33 | 0.190 |
Why?
|
| Equipment Design | 2 | 2012 | 185 | 0.190 |
Why?
|
| Postural Balance | 1 | 2022 | 122 | 0.190 |
Why?
|
| Surface Properties | 2 | 2019 | 133 | 0.180 |
Why?
|
| Orthopedics | 2 | 2013 | 129 | 0.180 |
Why?
|
| Refuse Disposal | 1 | 2020 | 3 | 0.180 |
Why?
|
| Antifibrinolytic Agents | 1 | 2020 | 23 | 0.180 |
Why?
|
| Tranexamic Acid | 1 | 2020 | 23 | 0.180 |
Why?
|
| Leukocyte Count | 1 | 2020 | 92 | 0.180 |
Why?
|
| Acetaminophen | 1 | 2020 | 22 | 0.180 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.180 |
Why?
|
| Los Angeles | 2 | 2017 | 7 | 0.170 |
Why?
|
| Arthroplasty | 2 | 2018 | 138 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2019 | 21 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 67 | 0.170 |
Why?
|
| Neutrophils | 1 | 2020 | 118 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 177 | 0.170 |
Why?
|
| Pain Perception | 1 | 2019 | 7 | 0.170 |
Why?
|
| Cell Differentiation | 1 | 2019 | 149 | 0.170 |
Why?
|
| Pelvis | 2 | 2016 | 30 | 0.160 |
Why?
|
| Oxycodone | 1 | 2019 | 6 | 0.160 |
Why?
|
| Survivorship | 1 | 2019 | 17 | 0.160 |
Why?
|
| Wound Healing | 2 | 2018 | 168 | 0.160 |
Why?
|
| Mobile Applications | 1 | 2019 | 24 | 0.160 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 161 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 35 | 0.160 |
Why?
|
| alpha-Defensins | 1 | 2018 | 3 | 0.160 |
Why?
|
| Ceramics | 2 | 2015 | 23 | 0.160 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 81 | 0.160 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 9 | 0.160 |
Why?
|
| Apoptosis | 1 | 2019 | 259 | 0.160 |
Why?
|
| Logistic Models | 2 | 2016 | 410 | 0.160 |
Why?
|
| Morphine | 1 | 2019 | 83 | 0.150 |
Why?
|
| Surgeons | 2 | 2019 | 76 | 0.150 |
Why?
|
| Bone Remodeling | 1 | 2018 | 44 | 0.150 |
Why?
|
| Databases, Factual | 2 | 2018 | 331 | 0.150 |
Why?
|
| Drainage | 1 | 2018 | 50 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 129 | 0.150 |
Why?
|
| Preoperative Period | 2 | 2020 | 66 | 0.150 |
Why?
|
| Arthritis, Infectious | 1 | 2018 | 58 | 0.150 |
Why?
|
| Knee | 1 | 2017 | 44 | 0.150 |
Why?
|
| Spine | 1 | 2018 | 123 | 0.140 |
Why?
|
| Motion | 1 | 2016 | 23 | 0.140 |
Why?
|
| Mupirocin | 1 | 2016 | 17 | 0.140 |
Why?
|
| Fascia Lata | 1 | 2016 | 8 | 0.140 |
Why?
|
| Sacrum | 1 | 2016 | 27 | 0.140 |
Why?
|
| Ions | 1 | 2016 | 54 | 0.140 |
Why?
|
| Thigh | 1 | 2016 | 35 | 0.140 |
Why?
|
| Patient Outcome Assessment | 1 | 2016 | 44 | 0.140 |
Why?
|
| Auditory Perception | 1 | 2016 | 36 | 0.130 |
Why?
|
| Chlorhexidine | 1 | 2016 | 61 | 0.130 |
Why?
|
| Stockings, Compression | 1 | 2015 | 2 | 0.130 |
Why?
|
| Midwestern United States | 1 | 2016 | 67 | 0.130 |
Why?
|
| Internal Fixators | 1 | 2016 | 52 | 0.130 |
Why?
|
| Tennessee | 1 | 2015 | 9 | 0.130 |
Why?
|
| Rats | 2 | 2019 | 873 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 332 | 0.130 |
Why?
|
| Great Lakes Region | 1 | 2015 | 1 | 0.130 |
Why?
|
| Preoperative Care | 2 | 2014 | 135 | 0.130 |
Why?
|
| Joint Capsule | 2 | 2012 | 43 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 24 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 59 | 0.120 |
Why?
|
| Alloys | 1 | 2015 | 92 | 0.120 |
Why?
|
| Regional Health Planning | 1 | 2014 | 4 | 0.120 |
Why?
|
| Chemoprevention | 1 | 2014 | 5 | 0.120 |
Why?
|
| Shoulder Joint | 2 | 2012 | 577 | 0.120 |
Why?
|
| Patients | 1 | 2015 | 31 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2014 | 24 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 744 | 0.120 |
Why?
|
| Software | 1 | 2014 | 72 | 0.120 |
Why?
|
| Arthritis, Juvenile | 1 | 2014 | 8 | 0.120 |
Why?
|
| Perception | 1 | 2015 | 83 | 0.120 |
Why?
|
| Knee Dislocation | 1 | 2014 | 7 | 0.120 |
Why?
|
| Femoral Nerve | 1 | 2014 | 9 | 0.120 |
Why?
|
| Survival Rate | 1 | 2015 | 376 | 0.120 |
Why?
|
| Obesity | 1 | 2017 | 289 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2014 | 67 | 0.120 |
Why?
|
| Amides | 1 | 2014 | 21 | 0.120 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2014 | 4 | 0.120 |
Why?
|
| Analgesia, Epidural | 1 | 2014 | 60 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 52 | 0.110 |
Why?
|
| Fluoroscopy | 1 | 2013 | 53 | 0.110 |
Why?
|
| Disability Evaluation | 1 | 2016 | 327 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 221 | 0.110 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 92 | 0.110 |
Why?
|
| Connective Tissue | 1 | 2013 | 26 | 0.110 |
Why?
|
| Nerve Block | 1 | 2014 | 62 | 0.110 |
Why?
|
| Pressure | 1 | 2013 | 61 | 0.110 |
Why?
|
| Leg | 1 | 2013 | 49 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2014 | 640 | 0.110 |
Why?
|
| Hip | 1 | 2013 | 39 | 0.110 |
Why?
|
| Femoral Neck Fractures | 1 | 2012 | 13 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 532 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 388 | 0.100 |
Why?
|
| Foreign-Body Migration | 1 | 2012 | 20 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2012 | 96 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2014 | 224 | 0.100 |
Why?
|
| Vasculitis | 1 | 2012 | 32 | 0.100 |
Why?
|
| Chromium Alloys | 1 | 2012 | 45 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 114 | 0.100 |
Why?
|
| Hemiarthroplasty | 1 | 2012 | 31 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2012 | 110 | 0.100 |
Why?
|
| Arthritis, Psoriatic | 1 | 2012 | 19 | 0.100 |
Why?
|
| Quality of Life | 1 | 2017 | 676 | 0.100 |
Why?
|
| Patellar Dislocation | 1 | 2012 | 21 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2011 | 33 | 0.100 |
Why?
|
| Computers, Handheld | 1 | 2011 | 13 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 463 | 0.100 |
Why?
|
| External Fixators | 1 | 2011 | 11 | 0.100 |
Why?
|
| Societies, Medical | 1 | 2013 | 190 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 474 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 40 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 325 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2011 | 58 | 0.090 |
Why?
|
| Shoulder Injuries | 1 | 2012 | 143 | 0.090 |
Why?
|
| Arthralgia | 1 | 2012 | 122 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 230 | 0.090 |
Why?
|
| Movement | 1 | 2011 | 145 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2012 | 180 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2013 | 492 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 970 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 3 | 2016 | 143 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 433 | 0.090 |
Why?
|
| Animals | 2 | 2019 | 4634 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 41 | 0.080 |
Why?
|
| Rotator Cuff Injuries | 1 | 2012 | 280 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2011 | 213 | 0.080 |
Why?
|
| Risk | 2 | 2019 | 216 | 0.070 |
Why?
|
| Elective Surgical Procedures | 2 | 2019 | 42 | 0.070 |
Why?
|
| Early Ambulation | 2 | 2019 | 20 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2019 | 286 | 0.070 |
Why?
|
| Medicare | 2 | 2015 | 123 | 0.060 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 6 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 4 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 12 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 558 | 0.050 |
Why?
|
| Silver | 1 | 2021 | 4 | 0.050 |
Why?
|
| Bandages | 1 | 2021 | 9 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2020 | 53 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 232 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 120 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2020 | 61 | 0.040 |
Why?
|
| Bone-Implant Interface | 1 | 2019 | 7 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 8 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 103 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 79 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 107 | 0.040 |
Why?
|
| Bone Resorption | 1 | 2019 | 95 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 78 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 323 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 411 | 0.040 |
Why?
|
| Body Weight | 1 | 2019 | 132 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 298 | 0.040 |
Why?
|
| Analgesics | 1 | 2019 | 108 | 0.040 |
Why?
|
| Colitis | 1 | 2017 | 37 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 141 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 194 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2016 | 25 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 506 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2016 | 85 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 68 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 18 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 158 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2015 | 26 | 0.030 |
Why?
|
| Medicaid | 1 | 2015 | 37 | 0.030 |
Why?
|
| Spain | 1 | 2014 | 20 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 704 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2015 | 54 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2014 | 27 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 7 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 4 | 0.030 |
Why?
|
| Aluminum Oxide | 1 | 2014 | 7 | 0.030 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2014 | 22 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 355 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 130 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 14 | 0.030 |
Why?
|
| New York City | 1 | 2014 | 18 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 119 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 96 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2016 | 176 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2015 | 70 | 0.030 |
Why?
|
| Hospitals | 1 | 2015 | 157 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 329 | 0.030 |
Why?
|
| Device Removal | 1 | 2014 | 86 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 105 | 0.030 |
Why?
|
| Linear Models | 1 | 2014 | 258 | 0.030 |
Why?
|
| Accidental Falls | 1 | 2014 | 117 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 194 | 0.030 |
Why?
|
| Fingers | 1 | 2012 | 11 | 0.030 |
Why?
|
| Dermatologic Agents | 1 | 2012 | 7 | 0.030 |
Why?
|
| Recurrence | 1 | 2012 | 352 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 101 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2012 | 92 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 223 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 270 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 347 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 93 | 0.020 |
Why?
|
| Polyethylenes | 1 | 2009 | 40 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 136 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1376 | 0.020 |
Why?
|